Penumbra (PEN) Cost of Revenue (2014 - 2026)
Penumbra (PEN) reported Cost of Revenue of $121.3 million for Q1 2026, up 12.09% year-over-year from $108.3 million in Q1 2025, and down 1.55% quarter-over-quarter from $123.3 million in Q4 2025.
Penumbra (PEN) Cost of Revenue (2014 - 2026) Analysis & Trends
Penumbra (PEN) has 13 years of Cost of Revenue data on file, last reported at $121.3 million in Q1 2026.
- Cost of Revenue for Q1 2026 came in at $121.3 million, up 12.09% year-over-year; the trailing twelve-month figure through Mar 2026 was $474.3 million (up 5.32% YoY), and the FY2025 annual result was $461.2 million, up 4.92% from the prior year.
- Cost of Revenue declined to $121.3 million in Q1 2026 per PEN's latest filing, from $123.3 million in the prior quarter.
- Over five years, Cost of Revenue peaked at $136.6 million in Q2 2024 and troughed at $74.3 million in Q2 2022.
- A 5-year average of $100.6 million and a median of $97.7 million in 2023 frame the typical range for Cost of Revenue.
- The sharpest annual moves came in 2024 and 2025: Cost of Revenue jumped 44.31% in 2024, then retreated 15.47% in 2025.
- A 5-year view of Cost of Revenue shows it stood at $82.8 million in 2022, then advanced by 18.0% to $97.7 million in 2023, then advanced by 7.28% to $104.8 million in 2024, then grew by 17.62% to $123.3 million in 2025, then dropped by 1.55% to $121.3 million in 2026.
- Business Quant data shows PEN's Cost of Revenue at $121.3 million in Q1 2026, $123.3 million in Q4 2025, and $114.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | 3.26 Bn |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 362.60 Mn |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | 481.00 Mn |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.51 Bn |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | 441.60 Mn |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | 891.20 Mn |
| 10 | Penumbra | 12.51 Bn | 11.90 Bn | 253.41 Mn | 121.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121.35 Mn |
| Mar 31, 2026 | 121.35 Mn |
| Dec 31, 2025 | 123.26 Mn |
| Dec 31, 2025 | 123.26 Mn |
| Sep 30, 2025 | 114.27 Mn |
| Sep 30, 2025 | 114.27 Mn |
| Jun 30, 2025 | 115.45 Mn |
| Jun 30, 2025 | 115.45 Mn |
| Mar 31, 2025 | 108.26 Mn |
| Mar 31, 2025 | 108.26 Mn |
| Dec 31, 2024 | 104.80 Mn |
| Dec 31, 2024 | 104.80 Mn |
| Sep 30, 2024 | 100.73 Mn |
| Sep 30, 2024 | 100.73 Mn |
| Jun 30, 2024 | 136.57 Mn |
| Jun 30, 2024 | 136.57 Mn |
| Mar 31, 2024 | 97.52 Mn |
| Mar 31, 2024 | 97.52 Mn |
| Dec 31, 2023 | 97.69 Mn |
| Dec 31, 2023 | 97.69 Mn |